Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Expiring Stock Options

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Jan 04, 2023 9:15am

138 Views

Post# 35202327

RE:RE:Expiring Stock Options

I've been watching the insider filings and haven't seen anything filed yet. I was under the impression they wouldn't be able to exercise without giving public notice.

Wino115 wrote: It may be in the annual proxy statements. There is also the ability to adjust expiry dates if conditions warrant it and Board approves. We'll only find out later if that's what happened to the year end ones or if they just exercised them and tucked them away.

PWIB123 wrote: Where are you all tracking the options granted that are expiring specific to the insiders? I see the options granted in the financial reports and the breakdown of the number of options owned by each director/executive officer in the annual report, but I don't see anything regarding option expiration dates.